Phoenix Biotech Acquisition Corp.
NASDAQ:PBAX
5.85 (USD) • At close February 14, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2022 | 2021 | |
|---|---|---|---|
| Assets: | |||
| Current Assets: | |||
| Cash & Cash Equivalents
| 3.327 | 0.476 | 1.099 |
| Short Term Investments
| 0 | 0 | 0 |
| Cash and Short Term Investments
| 3.327 | 0.476 | 1.099 |
| Net Receivables
| 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 |
| Other Current Assets
| 0.387 | 0.225 | 0.263 |
| Total Current Assets
| 3.714 | 42.367 | 1.361 |
| Non-Current Assets: | |||
| Property, Plant & Equipment, Net
| 1.993 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 178.5 |
| Tax Assets
| 0 | 0 | 0.07 |
| Other Non-Current Assets
| 0.5 | 0 | 0.148 |
| Total Non-Current Assets
| 2.493 | 0 | 178.717 |
| Total Assets
| 6.207 | 42.367 | 180.078 |
| Liabilities & Equity: | |||
| Current Liabilities: | |||
| Account Payables
| 4.507 | 1.653 | 0.014 |
| Short Term Debt
| 0.876 | 0.65 | 0 |
| Tax Payables
| 0 | 0.599 | 0.08 |
| Deferred Revenue
| 0 | 0 | 0 |
| Other Current Liabilities
| -2.489 | 27.846 | 0.003 |
| Total Current Liabilities
| 7.402 | 30.748 | 0.098 |
| Non-Current Liabilities: | |||
| Long Term Debt
| 0.699 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 9.15 | 0 |
| Total Non-Current Liabilities
| 0.699 | 9.15 | 9.15 |
| Total Liabilities
| 8.101 | 39.898 | 9.248 |
| Equity: | |||
| Preferred Stock
| 1.25 | 0 | 0 |
| Common Stock
| 0.086 | 13.225 | 178.501 |
| Retained Earnings
| -70.918 | -10.756 | -7.67 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 178.501 |
| Other Total Stockholders Equity
| 68.938 | 0 | 0 |
| Total Shareholders Equity
| -1.895 | 2.469 | 170.83 |
| Total Equity
| 0 | 2.469 | 170.83 |
| Total Liabilities & Shareholders Equity
| 6.207 | 42.367 | 180.078 |